Changes in plasma protein binding have little clinical relevance

被引：566

作者：

Benet, LZ ^{[1
]}

Hoener, BA ^{[1
]}

机构：

[1] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

10.1067/mcp.2002.121829

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：115 / 121

页数：7

共 20 条

[11] Rowland M., 2011, Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications, V4th ed.
[12] WHAT IS THE TRUE CLINICAL-SIGNIFICANCE OF PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS
SANSOM, LN
EVANS, AM
[J]. DRUG SAFETY, 1995, 12 (04) : 227 - 233
[13] PLASMA-PROTEIN DISPLACEMENT INTERACTIONS ARE RARELY OF CLINICAL SIGNIFICANCE
SELLERS, EM
[J]. PHARMACOLOGY, 1979, 18 (05) : 225 - 227
[14] INTERACTION BETWEEN DIFLUNISAL AND WARFARIN
SERLIN, MJ
MOSSMAN, S
SIBEON, RG
TEMPERO, KF
BRECKENRIDGE, AM
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) : 493 - 498
[15] SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358
[16] THUMMEL KE, 2001, GOODMAN GILMANS PHAR, P1924
[17] PLASMA AND TISSUE BINDING CONSIDERATIONS IN DRUG DISPOSITION
WILKINSON, GR
[J]. DRUG METABOLISM REVIEWS, 1983, 14 (03) : 427 - 465
[18] WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377
[19] WINTER ME, 1994, APPL THER, P313
[20] DIFFERENTIATION OF ABSORPTION AND FIRST-PASS GUT AND HEPATIC-METABOLISM IN HUMANS - STUDIES WITH CYCLOSPORINE
WU, CY
BENET, LZ
HEBERT, MF
GUPTA, SK
ROWLAND, M
GOMEZ, DY
WACHER, VJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (05) : 492 - 497